We found that HOXD9 was typically overexpressed in ATC tissues, had a favorable correlation with clinicopathological characteristics (tumor size, distant metastasis, and TNM stage), and was an independent prognostic predictor for ATC patients. This evidence concerns the gene HOXD9 and neoplasm.